Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series

SIMPLE SUMMARY: SARS-CoV-2 causes coronavirus disease (COVID-19) and poses a global health burden. Treatment strategies remain limited and mainly consist of dexamethasone; antiviral agents, such as remdesivir and molnupiravir; and SARS-CoV-2-specific monoclonal antibodies (mABs), including bamlanivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeckel, Göran Ramin, Hölscher, Silke Dorothea, Bürger, Christin, Jacob, Torid, Krekeler, Carolin, Shumilov, Evgenii, Reicherts, Christian, Bleckmann, Annalen, Lenz, Georg, Vollenberg, Richard, Tepasse, Phil-Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032833/
https://www.ncbi.nlm.nih.gov/pubmed/35448162
http://dx.doi.org/10.3390/curroncol29040188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032833/
https://www.ncbi.nlm.nih.gov/pubmed/35448162
http://dx.doi.org/10.3390/curroncol29040188

Ejemplares similares